MedTrace Logo

Adding Dexmedetomidine Versus Ketamine to Bupivacaine in Fluoroscopy Guided Caudal Analgesia for Lumbosacral Surgeries

NCT07573969 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2026-05-07

No results posted yet for this study

Summary

This study will evaluate the effect of adding dexmedetomidine to bupivacaine compared to ketamine in the caudal block on perioperative analgesia in patients undergoing lumbosacral surgeries under general anesthesia.

Conditions

  • Perioperative Analgesia

Interventions

DRUG

Group C (plain bupivacaine (0.125%))

The patients will receive 20ml plain bupivacaine (0.125%) in the caudal block

DRUG

Group D (plain bupivacaine (0.125%) + 2μg/kg dexmedetomidine)

The patients will receive 20ml plain bupivacaine (0.125%) + 2μg/kg dexmedetomidine in the caudal block

DRUG

Group K (plain bupivacaine (0.125%) + 1mg/kg ketamine)

The patients will receive 20ml plain bupivacaine (0.125%) + 1mg/kg ketamine in the caudal block

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2027-05-31
Completion
2027-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07573969 on ClinicalTrials.gov